DISCLAIMER The following presenta?on contains data provided to OMG. - - PowerPoint PPT Presentation

www.bestppt.com

ORGANIC MEDICAL GROWTH OMG3 INC

CORPORATE PRESENTATION Q2 2019

www.bestppt.com

DISCLAIMER

The following presenta?on contains data provided to OMG. As such, OMG has taken all reasonable care in reproducing the informa?on herein. Material in this presenta?on may contain technical or other inaccuracies,

• missions, or typographical errors, for which OMG assumes no responsibility. OMG does not warrant or make any

representa?ons regarding the use, validity, accuracy, completeness or reliability of any claims, statements or informa?on in this presenta?on. Under no circumstances, including, but not limited to, negligence, shall OMG be liable for any direct, indirect, special, incidental, consequen?al, or other damages, including but not limited to, loss

• f programs, loss of data, loss of use of computer of other systems, or loss of profits, whether or not advised of the

possibility of damage, arising from the use, or inability to use, the material in this presenta?on. The informa?on presented herein is not a subs?tute for independent professional advice before making investment decisions. FORWARD-LOOKING STATEMENTS This presenta?on may contain forward-looking statements, including but not limited to comments regarding predic?ons and projec?ons. Forward-looking statements address future events and condi?ons and therefore involve inherent risks and uncertain?es. Actual results may differ materially from those currently an?cipated in such statements.

www.organicmedicalgrowth.com

COMPANY PURPOSE

3

OMG’s purpose is to transform and distribute cannabis deriva?ves and products throughout Colombia and

• ther interna?onal markets.

OMG secures raw materials through the produc?on of its mul?ple Licensed Producers (LPs) on organic cer?fied farms throughout Colombia.

BRANDS OIL

LP LP LP LP

INTERNATIONAL LABS

8,350 PHARMACIES BIOMASS

www.organicmedicalgrowth.com

CHALLENGES

4

• Colombian cannabis industry is s?ll in the early development stage.
• The prac@ces to produce cannabis in Colombia are not standardized.
• Licensed producers have limited access to technology and partners who

have transforma?on, distribu?on, export and finance exper?se.

• Many licenses are being revoked for various reasons.
• Licensed producers are asking for large sums of money for the purchase
• f sub-standard opera?ons.
• Financing for cannabis within Colombia is extremely challenging.

www.organicmedicalgrowth.com

THE SOLUTION

5

• OMG will finance and consolidate the produc?on of

mul?ple Licensed Producers (LP).

• OMG has access to mul?ple licenses in each category

including: seed licenses, non-psychoac@ve licences, psycho-ac@ve licenses, transforma@on licenses and export licenses.

• OMG will provide world-class exper@se and technology

in cannabis produc?on, cul?va?on and extrac?on.

• Distribu?on to more than 8,350 pharmacies throughout

Colombia.

• Finalizing distribu@on (off-take) agreements in Germany,

Australia and Portugal for the cannabis oil.

www.organicmedicalgrowth.com

WHY INVEST IN OMG

6

• Global cannabis oil awakening: Growing appe?te and worldwide demand for low-cost high-standard
• il.
• Legal framework in Canada and Colombia: Ability to raise money in Canada and produce in

Colombia.

• Growing condi?ons: Produc?on costs in Colombia are $0.05 CAD per gram compared to around

$1.50 CAD per gram in Canada. This is due to lower wages and beZer growing condi?ons across Colombia.

• Only one year a[er the legaliza?on of large-scale produc?on, Colombia is poised to be the largest

cannabis producer in the world with 44% of the world produc@on authorized by the Interna?onal Narco?cs Control Board (INCB) for this year.

www.organicmedicalgrowth.com

MARKET POTENTIAL

7

• Cannabis is expected to disrupt virtually every consumer industry. Legal cannabis became a US$12

billion global market in 2018 with exponen?al growth ahead.(1)

• While the total global market for cannabis, both legal and illegal, stands at US$150 billion today, the

global market research company Euromonitor Interna?onal expects the legal market to grow to 77%

• f total sales, reaching US$166 billion by 2025.(2)
• Medical marijuana emerged as the largest marijuana type segment in 2016 and is es?mated to be

valued at $US100.03 billion by 2025. CBD market will hit $US22 billion by 2022.(3)

• In Colombia, the emerging cannabis industry has the opportunity to supply an es?mated market of 6

million pa@ents.(4)

(1) BusinessWire (February 2019) Global Legal Cannabis Market to Reach US$166 Billion by 2025. https://www.businesswire.com/news/home/20190226005126/en/Global-Legal-Cannabis-Market-Reach-US166-Billion (2) BusinessWire (February 2019) Global Legal Cannabis Market to Reach US$166 Billion by 2025. https://www.businesswire.com/news/home/20190226005126/en/Global-Legal-Cannabis-Market-Reach-US166-Billion (3) The BrightField Group: CBD Market Report (September 2018) Exclusive: New Report Predicts CBD Market Will Hit $22 Billion by 2022. https://www.rollingstone.com/culture/culture-news/new-study-cbd-market-22-billion-2022-722852/ (4) Cannabis Investing News. (December 2018) Latin America’s Emerging Medical Cannabis Market. https://investingnews.com/innspired/latin-americas-medical-cannabis-market/

www.organicmedicalgrowth.com

COMPETITION / ALTERNATIVES

8

LICENSES 8 LICENSED PRODUCERS: 5 NON-PSYCHOACTIVE LICENSES, 3 PSYCHOACTIVE LICENSES, 3 TRANSFORMATION, 7 SEED PERMITS 3 LICENSED PRODUCERS (2 COLOMBIA, 1 ARGENTINA) 2 TRANSFORMATION 1 EXPORT LICENSE (ARGENTINA) 1 SEED LICENSE 3 LICENSED PRODUCERS (COLOMBIA, CHILE, URUGUAY) 2 TRANSFORMATION, 1 EXPORT LICENSE, 2 DISTRIBUTION LICENSES 1 LICENSED PRODUCER: 1 NON-PSYCHOACTIVE LICENSES, 1 PSYCHOACTIVE LICENSES, 1 TRANSFORMATION, 1 EXPORT LICENSE, 20 SEED LICENSES 8 LICENSED PRODUCERS 15 LICENSED SUBSIDIARIES LAND CAPACITY 140 HECTARES OPTION TO EXPAND: 3,000 HECTARES 48 HECTARES OPTION TO EXPAND: 1,000 HECTARES 17.2 HECTARES (IBAGUE COLOMBIA) 25 HECTARES (FUNDACIÓN DAYA/ DAYACANN IN CHILE) 5 HECTARES (NETTAGROW THROUGH CANNAPUR IN URUGUAY) 12.1 HECTARES 2019 Target: 20 HECTARES OPTION TO EXPAND: 1,000 1,600 HECTARES EUROPE (AgroPro) 29 HECTARES (Medicine Hat) 8 HECTARES Aurora Sky Greenhouse 12 HECTARES Aurora Sun Greenhouse CANNABOLAND EXTENSIONS 5 LICENSED PRODUCERS WITH A TOTAL OF 8 LICENSES N/A N/A N/A N/A CANNABOLAND EXTENSIONS LAND CAPACITY 2,000 HECTARES N/A N/A N/A N/a DISTRIBUTION 8,350 pharmacies in Colombia Off take Lexamed Cannabis Avatara (Argentina, MarketingWorldwide, El Manantial, Madre Terra DIXIE BRANDS (U.S). CannaB Patient Association2 Farmatodo, ILANS, Zerenia (COLOMBIA) UBIQUO (MEDELLIN), 111INO, EUGENE PELOTON (CANADA) CANNGROUP LTD. (AUSTRALIA) PEDANIOS (GERMANY), Agropro UAB, Farmacias Magistrales, Czech Medical Herbs INTERNATIONAL BRAND PARTNERSHIPS ELIXINOL (USA) ENDOCA SD Cannabis

• DR. KERKLANN (USA)

JV with CANNAVA (Argentina) India Colorada (Colombia) CANNAPUR DIXIE BRANDS (U.S). Mino Labs NamasteMD, High Tide, MedReleaf, CanniMed Therapeutics, Cann Group, Hempco Food and Fiber, ICC Labs, Agropro UAB, Whistler Medical Marijuana Corporation

VALUATION $25M MARKET CAP $57M MARKET CAP $400M MARKET CAP $969.1M MARKET CAP $6.3B MARKET CAP

www.organicmedicalgrowth.com

COMPETITION / ALTERNATIVES (CONTINUED)

9

As opposed to compe?tors:

• OMG has secured mul@ple producers with various

licenses therefore diversifying the risk of losing access to cri?cal licenses and extensions.

• OMG has access to world-class exper@se and

technology therefore able to propagate and share knowledge through its network of LPs.

• OMG is strategically posi?oned to become the

largest producer and distributor of cannabis products in La?n America.

www.organicmedicalgrowth.com

BUSINESS MODEL

10

PROFIT AT EVERY STAGE

PRODUCTION TRANSFORMATION DISTRIBUTION

www.organicmedicalgrowth.com

LP PRODUCTION

11

• OMG has secured 8 dis?nct licensed producers (LP) to

produce and transform THC and CBD from licensed areas, represen?ng over 140 hectares with a possibility to extend to 3,000 hectares. Together, these LPs hold a total

• f 11 licenses (5 non-psychoac?ve, 3 psychoac?ve, 3

transforma?on) as well as 7 seed permits. OMG will implement Standard Opera?ng Procedures to control cost and quality.

UNIT OF PRODUCTION

www.organicmedicalgrowth.com

CANNABOLAND PRODUCTION

12

• Cannabolland is a business cluster that groups

associated cannabis companies with cannabis related licenses for the cul?va?on, transforma?on and export of CBD oil and cannabis-based products.

• Through its Joint Venture with Cannaboland, OMG

will have the ability to produce on the extensions

• f 5 LPs to produce and transform THC and CBD

from a new licensed area (controlled by Cannaboland) represen?ng 140 hectares of land with the possibility to extend this produc?on to 2,000 hectares. Together, these LPs hold a total of 8 licenses.

ZONA SEMI OUTDOOR

www.organicmedicalgrowth.com

TRANSFORMATION

13

• Through its strategic partners, OMG will provide exper@se

and technology related to the produc@on, cul@va@on and extrac@on to LPs in Colombia. This will include breeding techniques; cul?va?on, nursery and extrac?on standard

• pera?ng procedures.
• OMG will transform cannabis oil for cosme@cs through

Improfarme, a GMP cer?fied 250,000 sq [ lab for which OMG has currently an op?on to purchase. OMG will transform pharmaceu@cal (GMP and GLP) grade oil through BIOCHEM, a 2.5M sq [ facility.

www.organicmedicalgrowth.com

DISTRIBUTION

14

• OMG House brand and co-branded offering of topical products:

Through its partners network, OMG products will be sold in more than 8,350 points of sale across Colombia. Similar deals with pharmaceu?cal chains are being nego?ated in Peru, Ecuador, Panama, Brazil and Uruguay.

• Orthopaedic supply with cannabis oil: OMG is developing a product

line that will combine a series of orthopaedic devices with cannabis

• il.
• Distribu@on of 3rd par@es offering: OMG signed the master

distribu?on agreement with Endoca for the distribu?on of Endoca’s products in Colombia and Brazil. OMG is finalizing the terms of master license agreements with Dr. Kerklaan and Elixinol for the distribu?on of their products within its network of 8,350 points of sale as well as the off take agreements for selling the oil produced in Colombia by OMG’s JV partners.

• Off take agreements: OMG is currently finalizing off take agreements

with partners in Germany, Portugal and Australia for the purchase of cannabis and cannabis oil from farms in Colombia.

www.organicmedicalgrowth.com

JOINT VENTURE IN ITALY

15

• OMG is developing a strategic posi?on to enter the European market by signing an

agreement with Geranta Advanced Agriculture (GERANTA) for the produc?on of

• cannabis. OMG will have access to GERANTA’s distribu?on network - 14,000

pharmacies across Italy.

• GERANTA will have 66,000 lbs of hemp from the new 2019 produc?on, as well as

22,000 lbs of selected hemp coming from its partners’ in 2019. An addi?onal 1,300,000 lbs of product will be used for extrac?on, which will be done in a 250 sqm GMP cer@fied laboratory.

• Highlights on GERANTA:
• 1. Liguria: Two master greenhouses of 52,500 sq[ and 46,000 sq[.
• 2. Piedmont: A 1,600,000 sq[ of available land with fully automated 750,000 seed

plants process and a GMP cer?fied facility.

• 3. Sardinia: 430,000 sq [ and 54,000 sq [ growth areas.
• 4. Tuscany: 32,000,000 sq [ growth area.
• Es?mated profit of GERANTA: $24 million EUR in 2019, $60 million EUR in 2020,

$122 million EUR in 2021.

www.organicmedicalgrowth.com

LEADERSHIP TEAM

16

ANDRE HALLEY Chairman

• Mr. Halley previously held senior

execu?ve and board member posi?ons in a variety of telecom companies worldwide, including Bell, Teleglobe, Orbcomm, TIW and

• Oreedoo. His current posi?ons

include: Execu?ve Chairman of Prevtec Microbia Inc. a biotech company, Chairman of the Board at 2KLIC INC, an IoT Open Plamorm solu?on provider and Board Member

• f Alzheimer Society of Canada.

JORGE DIAZ Founder & CEO

With 20 years of extensive business experience, Mr. Diaz (MBA, Financial Engineer Graduate) has been a board member of numerous firms in Colombia, USA and Canada. Past posi?ons include: Advisor to former President of Colombia

• Mr. Juan Manuel Santos and former

President Mr. Alvaro Uribe Velez, Business Developer Manager for PWC, Advisor to Former Vice-President of Colombia Angelino Garzón.

PIERRE GAUTHIER Founding Partner

• Mr. Gauthier is the founder and CEO of

Seed Capital Inc (SEED), a venture fund that has been the first round investor in

• ver 20 companies that have been listed
• n recognized securi?es exchanges. SEED

and associates have funded mining projects located in over 10 countries, and have raised over $500 million over the last 20 years. Recently, SEED has focused on the financing of innova?on and proprietary technologies in various industries.

www.organicmedicalgrowth.com

ADVISORS

17

• Mr. Tamayo was a Major General in the Na?onal

Army of Colombia and he worked for more than thirty-seven years as an officer, both in

• pera?onal and administra?ve areas: logis?cs,

human talent management, human rights and Interna?onal Humanitarian Law. He was awarded numerous medals and honours for his

• utstanding service and excep?onal results. Ms.

Tamayo was also a member of several defence interna?onal commiZees such as ONUCA, ONUSAL and JID. He currently works as a private Security Consultant. MARCO LINO TAMAYO Director / Security Advisor

• Mr. Hughes is Chairman and CEO of Next

Green Wave (CNSX:NGW) a publicly listed Cannabis company. He is an integrated marke?ng communica?ons and innova?ons professional of 15+ years. Mr. Hughes has held board level posi?ons for mul?ple companies and has success and experience in ventu re cap i tal ser vi ces an d th e commercializa?on of private and public companies across the globe, in par?cular: North America, Australia, and the Asia Pacific

• Region. He is currently a corporate advisor to

mul?ple listed companies on the CSE and TSXv. LEIGH HUGHES Advisor

• Mr. Rodriguez has held important posi?ons in

both private and public sectors in Colombia. He was the Head of the Colombian Housing Fund, Director of the Na?onal Service of Learning (SENA), Director of the Na?onal Civil Service, the Colombian delegate in the Interna?onal Labor Organiza?on, President of the Na?onal Social Welfare Fund, as well as a candidate for the Colombian Senate. He did postgraduate studies in telecommunica?ons as well as studies in strategic planning, alterna?ve means of conflict resolu?on, as well as notary and registry law. Mr. Rodriguez was a professor at several pres?gious universi?es in the country. CARLOS HUMBERTO ISAZA RODRIGUEZ Director / Strategy Advisor

www.organicmedicalgrowth.com

OPERATIONAL TEAM

18

As CDO for FairGreen Capital Partners and managing director of its North American and Canadian regions, Ms. Asfour has 10+ years of management and strategy development

• experience. Previously, Ms. Asfour successfully

expanded the business of TG Capital, through deal sourcing, strategy and development of successful start-ups and took a hands-on approach to the companies she successfully expanded and brought to market. Ms. Asfour is a recipient of the pres?gious Founda?on Montreal Young Entrepreneur Award, holds an MBA from Herzing University and an undergraduate degree in Poli?cal Sciences from Concordia University. TARA ASFOUR Executive Vice President

• Ms. Acosta is an expert in corporate governance

and has supported private placements transac?ons in Canada, securi?es administra?on and going public transac?ons in various industries such as mining, technology and agribusiness. Ms. Acosta has managed business rela?ons for interna?onal Public-private partnership (PPP), suppor?ng interna?onal alliances, joint ventures transac?ons, subsidiaries incorpora?on and acquirement in Cuba, Bolivia and other parts of Central and South America. She works closely with accounts and auditors departments. Ms. Acosta is an accredited Colombian lawyer and MSc in Globalisa?on, Sustainable development and social regula?on (University of Laussane, Switzeland). PILAR ACOSTA VP Legal & Corporate

• Ms. Zivkovic is a an experienced marke?ng

professional with previous job posi?ons in private and public sector. She has seven years

• f work experience for Deutsche Telekom, the

leading European telecommunica?on provider. She currently works as a consultant in the area

• f Communica?ons and Investor Rela?ons for

several Montreal based companies. Ms. Zivkovic held posi?ons in Corporate Strategy and Business Development, Marke?ng C o m m u n i c a ? o n s , P R & C o r p o r a t e Communica?ons and CSR (Dona?on and Sponsorship). MARIJA ZIVKOVIC Communications & IR Manager

18

www.organicmedicalgrowth.com

FINANCIAL FORECAST

2019 2020 2021 Capital Expenditure 30,000,000 100,000,000 Produc?on Total unit crops 5 111 225 Total revenue 6,480,000 158,760,000 324,000,000 OMG produc?on EBITDA 3,175,200 77,792,400 113,400,000 Distribu?on Revenue OMG product 720,000 1,346,400 1,730,520 Private label 576,000 1,188,000 1,639,440 Interna?onal brand 960,000 1,689,600 2,125,200 Other products 288,000 528,000 667,920 Total distribu?on revenue 2,544,000 4,752,000 6,163,080 OMG distribu?on EBITDA 1,335,600 2,494,800 3,235,617 OMG EBITDA 4,510,800 80,287,200 116,635,617

www.organicmedicalgrowth.com

PROFORMA CAPITAL STRUCTURE

20

CURRENT Issued to founders 10,000,000 shares Issued first round $1,500,000 (at $0.05 per share) 30,000,000 shares Issued to strategic IP partner for Colombia 4,200,000 shares Partners ROUND $1,500,000 (at $0.25 per share) 6,000,000 shares TOTAL ISSUED 50,200,000 shares Strategic round $10,000,000 (at $0.50 to $0.75 per share) 20,000,000 shares Pre-IPO Round $30,000,000 (at $1.00 to $5.00 per share) concomitant to IPO 30,000,000 Shares TOTAL ISSUED POST-IPO 100,200,000 shares

www.organicmedicalgrowth.com

USE OF PROCEEDS

21

ROUND Partner Strategic Pre-IPO Post-IPO 2020

UNITS OF PRODUCTION

$500K $4M $5M $25 M

UNITS OF PRODUCTION EXTENSIONS

$4M $10 M $30 M

DISTRIBUTION

$250K $1M $5 M

WORKING CAPITAL

$250K $1M $5M $10 M

LAB

$10M $30M TOTAL $1M $10M $30M $100 M

www.organicmedicalgrowth.com

OUR VISION

22

To become the largest producer and distributor of cannabis in Colombia using economies of scale to export the lowest cost GMP cer?fied cannabis

• il in the world.

www.bestppt.com 23

Organic Medical Growth OMG3 Inc. 230 Notre Dame West Montreal, QC H2Y 1T3 CANADA

CONTACT US

Jorge Diaz

Founder & CEO jd@organicmedicalgrowth.com 514.710.2805

Pierre Gauthier

Founding Partner pg@organicmedicalgrowth.com 514.299.0881